Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06646939 · ClinicalTrials.gov registry record · NA
Comparison of Community Reintegration Interventions When Using a Simulated Environment
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT06646939: Clinical Trial NA study, sponsored by Weill Medical College of Cornell University.
NCT06646939 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06646939, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The investigators believe that rehabilitation specialists will use community reintegration treatments more if a simulated environment is available.
Primary Outcome
Current Procedural Terminology (CPT) code 9753, is a billing code where one unit of the code is used for each 15 minutes the provider spends with the patient teaching them return to work and the community. For this measure, the therapist will document the amount of time spent performing each study activity when utilizing the simulated environment, as measured by number of 15-minute units billed.. This will be compared to units billed in 2015 - 2019 prior to the implementation of the simulated
Interventions
- BEHAVIORAL PT and OT with a simulated environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
Why NCT06646939 stopped before completion
NCT06646939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which PT and OT with a simulated environment is the first listed.
NCT06646939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06646939 about?
NCT06646939 is a clinical study titled "Comparison of Community Reintegration Interventions When Using a Simulated Environment". The investigators believe that rehabilitation specialists will use community reintegration treatments more if a simulated environment is available.
What is the current status of trial NCT06646939?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2023-07-05. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT06646939?
The interventions under investigation include: PT and OT with a simulated environment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06646939?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06646939's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI